Sponsored by

UBS Asset Management

UBS Asset Management is a global large-scale and diversified asset manager, with a presence in 23 markets. We offer investment capabilities and styles across all major traditional and alternative asset classes – from active to passive, including a comprehensive sustainable offering.

Our goal is to bring our clients the ideas, understanding and clarity to help them to deliver on their investment priorities and values, without compromise. Our global capabilities include equity, fixed income, currency, real estate, infrastructure, private equity and hedge fund investment that can be combined into customised solutions and multi-asset strategies.

To meet investors’ financial and sustainability goals, we offer sustainable and impact investing strategies across a range of asset classes, from environmental, social and corporate governance integration to impact investing including investment themes such as renewable energy, environmental stewardship, social integration, health care, resource efficiency and demographics.

We also offer tailored solutions that span the sustainability spectrum, including ESG integration, tilt toward a specific E, S, or G factor, thematic, positive screening, impact or exclusions. Sustainability is also an intrinsic part of the investment decision-making process across many of our active strategies. ESG factors are considered using our proprietary ESG Risk Dashboard. This information also feed into our stewardship process where we actively monitor and engage with any flagged companies to help them to make progress towards transitioning to a lower carbon future.

mallowstreet Dinner: Solving a Real Estate Supply Challenge for the UK Life Science Sector

The Covid-19 pandemic has brought the relevance of the life science sector to the forefront of our minds. The importance of the sector to the research, development and manufacture of often life-saving drugs is clear.

The UK life science market is the largest in Europe. However, the sector in the UK faces a critical challenge – an undersupply of best-in-class life science facilities and real estate. Biopharma companies have a demand. Can we meet the supply challenge?

Join us to hear more about our UK Life Sciences real estate capabilities on Thursday, the 20th of April 2023. We will assess the investment case, demystify life sciences and highlight the positive social impacts of the sector.

This event is FREE to attend for investment decision makers and their advisers, and is accredited for CPD points by the Pensions Management Institute (PMI).

Speakers

Olivia Drew
Olivia Drew is the portfolio manager for the UK Life Sciences strategy, and is the lead investment manager across the vehicle.
She was previously a Transactions Manager for Real Estate UK (RE-UK), a business which forms part of Real Estate & Private Markets (REPM) business within UBS Asset Management (UBS-AM). Olivia also had responsibilities across the REPM business on ESG strategies, supporting the growth of the sustainable product shelf and integrating ESG policies across the platform.
She joined UBS-AM in December 2017 as a member of the RE-UK team, providing support to several Funds and segregated mandates within the UK platform. Prior to joining UBS-AM, Olivia worked at M&G Investments (2014-2017), first as a graduate trainee, and then as an analyst specializing in long lease property funds.
Olivia is a CFA charterholder, and also holds the Investment Management Certificate (IMC).

Program

6:30 PM Guest Arrival and Welcome Drinks
7:00 PM Seated for Dinner
7:05 PM Service begins followed by Presentation and Discussion
9:00 PM End

mallowstreet Dinner: Solving a Real Estate Supply Challenge for the UK Life Science Sector

Speakers

Program

6:30 PM Guest Arrival and Welcome Drinks

7:00 PM Seated for Dinner

7:05 PM Service begins followed by Presentation and Discussion

9:00 PM End